Sustained Neuroprotection From a Single Intravitreal Injection of PGJ2in a Rodent Model of Anterior Ischemic Optic Neuropathy

Volume: 54, Issue: 12, Pages: 7402 - 7402
Published: Nov 8, 2013
Abstract
Purpose.: Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common cause of sudden optic nerve–related vision loss in persons older than 50 in the United States. There currently is no treatment for this disorder. We previously showed that systemic administration of 15-deoxy, delta (12, 14) prostaglandin J2 (PGJ2) is neuroprotective in our rodent model of AION (rAION). In this study, we determined if a single intravitreal (IVT)...
Paper Details
Title
Sustained Neuroprotection From a Single Intravitreal Injection of PGJ2in a Rodent Model of Anterior Ischemic Optic Neuropathy
Published Date
Nov 8, 2013
Volume
54
Issue
12
Pages
7402 - 7402
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.